Alnylam Pharmaceuticals (ALNY) Revenue US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Revenue, bln rub | ? | 219.8 | 492.9 | 844.3 | 1 037 | 1 828 | 2 014 | ||
Changes by years, y/y, % | +193% | +124% | +71% | +23% | +76% | +89.5% |
Alnylam Pharmaceuticals. Revenue US GAAP, bln rub
Alnylam Pharmaceuticals. Revenue US GAAP, changes, %
Alnylam Pharmaceuticals. Revenue US GAAP, sum by quarters, bln rub
Alnylam Pharmaceuticals (ALNY) Revenue US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Revenue, bln rub | ? | 750.5 | 439.7 | 494.3 | 659.8 | 420.1 | 2 014 | |
Changes by years, y/y, % | +184% | +31% | +55% | +107% | -44% | |||
Changes by quarters, q/q, % | +135% | -41% | +12% | +33% | -36% |